Stoke Therapeutics, Inc. (STOK)

Typically moves ±8.98% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-04 APPROXIMATE

Across 29 earnings reports since Aug 14, 2019, Stoke Therapeutics, Inc. (STOK) has a clear post-earnings pattern. It moves ±8.98% on average after reporting and finishes higher 51.7% of the time. Its largest post-earnings gain was +58.31% (Mar 25, 2024) and its largest decline was -25.3% (Nov 14, 2022). The next earnings report is predicted for 2026-11-04 (approximate).

Earnings reactions

How STOK moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±8.98%

Positive %

51.7%

Negative %

48.3%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 03, 2026	☽ POST	+7%	open_in_new
May 07, 2026	☽ POST	+0.4%	open_in_new
Jan 12, 2026	☀ PRE	-10.44%	open_in_new
Nov 04, 2025	☽ POST	-9.94%	open_in_new
Aug 12, 2025	☽ POST	+24.98%	open_in_new
May 13, 2025	☀ PRE	-7.56%	open_in_new
Mar 18, 2025	☀ PRE	-1.44%	open_in_new
Nov 05, 2024	☀ PRE	-0.38%	open_in_new
Aug 07, 2024	☀ PRE	-3.65%	open_in_new
May 06, 2024	☀ PRE	-1.25%	open_in_new
Mar 25, 2024	☽ POST	+58.31%	open_in_new
Nov 07, 2023	☀ PRE	+12.53%	open_in_new
Aug 07, 2023	☀ PRE	-4.41%	open_in_new
May 04, 2023	☀ PRE	+12.96%	open_in_new
Mar 06, 2023	☀ PRE	+4.64%	open_in_new
Nov 14, 2022	☀ PRE	-25.3%	open_in_new
Aug 08, 2022	☀ PRE	+26.03%	open_in_new
May 10, 2022	☀ PRE	+7.96%	open_in_new
Mar 10, 2022	☀ PRE	-0.91%	open_in_new
Nov 08, 2021	☀ PRE	+2.62%	open_in_new
Aug 10, 2021	☀ PRE	-1.56%	open_in_new
May 10, 2021	☀ PRE	+1.57%	open_in_new
Mar 09, 2021	☀ PRE	+2.77%	open_in_new
Nov 12, 2020	☀ PRE	-2.34%	open_in_new
Aug 10, 2020	☀ PRE	+5.15%	open_in_new
May 15, 2020	☀ PRE	+3.8%	open_in_new
Mar 23, 2020	☀ PRE	-11.66%	open_in_new
Nov 12, 2019	☀ PRE	-7.99%	open_in_new
Aug 14, 2019	☀ PRE	+0.9%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±8.98%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 24 →

Funds holding

$634240248

Total value held

Buying

17 added · 5 reduced

Blackrock, Inc.

$192307120 +9.13%

Morgan Stanley

$112975453 +0.86%

Toronto Dominion Bank

$103829002 Held

State Street Corp

$93325293 +25.29%

Janus Henderson Group Plc

$52455703 NEW BUY

SEC Filing Types

description SCHEDULE 13G/A

21 chevron_right

description SC 13G

12 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260903	open_in_new SEC.gov
4	20260818	open_in_new SEC.gov
4	20260818	open_in_new SEC.gov
4	20260818	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260812	open_in_new SEC.gov
SCHEDULE 13G/A	20260806	open_in_new SEC.gov
4	20260805	open_in_new SEC.gov
10-Q	20260803	open_in_new SEC.gov
144	20260803	open_in_new SEC.gov

Frequently asked about STOK earnings

When does Stoke Therapeutics, Inc. report earnings next? expand_more

Stoke Therapeutics, Inc. (STOK)'s next earnings date is approximate for 2026-11-04. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does STOK stock move after earnings? expand_more

Over 29 reports, STOK has moved an average of ±8.98% the session after earnings, closing higher 51.7% of the time.

What was STOK's biggest post-earnings move? expand_more

STOK's largest post-earnings gain on record was +58.31% on Mar 25, 2024, and its largest decline was -25.3% on Nov 14, 2022.

Where can I find Stoke Therapeutics, Inc.'s SEC filings? expand_more

All of Stoke Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.